Fractyl Health, Inc.
GUTSBiotechnology
$0.99+11.40%As of Oct 29vs prior close
- Market cap
- $13.2M
- P/E (TTM)
- –
- From 52W high
- −96.51%
- EPS (YE25)
- -$1.86
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
13
Fragile PremiumBottom 4% of the scored universe
Growth—
Quality28
Value17
Momentum28
Resilience25
Growth
$0revenue, YE25
YE23 $120KYE25 $0
Connections
Revenue to profitQ4 YE24
The operating loss was 840333% of revenue, wider by 654890 pts on a year.
Who owns it
1fund, 1 tracked portfolio